tweetindex
TH

Genetic Engineering & Biotechnology News

@GENbio · New Rochelle, NY · joined 15 Apr 2009

Serving the biotech industry since 1981. EIC @johnsterling4; publisher @liebertpub Subscribe to GEN: https://t.co/KzqMccOt9Q

89 615Followers
3 342Following
71 783Posts total
13.9KViews on collected posts

โพสต์ล่าสุด

Don't Miss Out! One Standard, Multiple Platforms: ICH Q2(R2) Qualification of Host Cell Protein Analysis by LC–MS/MS Register for this FREE webinar sponsored by USP: https://t.co/qer9vxgI2b #Biopharmaceuticals #Proteins #MonoclonalAntibodies https://t.co/NcE8jTSHgq
464 views · 2 likes · 2 reposts · 0 replies Open on X →
Prophylactic Phage Therapy Protects Mice Against Oral Salmonella Infection Researchers suggest lyto-lysogen strategy could feasibly be used to target other infections @virginia_tech #antibioticresistance #bacteriophages #Salmonellainfection #mice https://t.co/H1t2x8yZ4G 548 views · 4 likes · 3 reposts · 0 replies Open on X →
Prime Assembly Expands Genome Editing with Precise, Large-Scale DNA Integration A new genome-editing method, prime assembly, precisely inserts long DNA sequences into targeted genomic locations @danielevanbauer @BostonChildrens #CRISPR #genetherapy #DNA https://t.co/Iggy5kh5en 850 views · 15 likes · 1 reposts · 1 replies Open on X →
Consolidating Antibody Discovery Data with an AI Platform #FairJourneyBio runs scientific discovery programs of genuine depth and complexity across multiple international sites @SapioSciences #antibodies #AI #drugdiscovery https://t.co/BzPDquGqiA 1.6K views · 13 likes · 2 reposts · 2 replies Open on X →
Unlock new insights in microbiome research! Discover how anaerobic workflows and metabolic phenotyping advance functional analysis. Download your free eBook: https://t.co/12BgCMk7yV @BiologInc #Microbiome #NGS #Biomarkers https://t.co/tegvE6f9IX
1.1K views · 8 likes · 3 reposts · 1 replies Open on X →
Immune Cells Driving Alzheimer’s-Like Neurodegeneration Traced to Lymph Nodes Results show that eliminating dendritic cells from the #lymphnodes wiped out elevated levels of #Tcells in mice, and slowed cognitive decline @washumedicine #Alzheimersdisease https://t.co/94aiHrVwCD 1.6K views · 17 likes · 9 reposts · 0 replies Open on X →
Cancer Drug Reduces SIV Reservoir in Macaques, May Inform HIV Cure Strategies Venetoclax, a cancer drug that inhibits BCL-2, reduced the intact SIV reservoir in #macaques. This may support future #HIV cure strategies @EmoryUniversity #anticancerdrugs https://t.co/PL2kLjaHXb 1K views · 2 likes · 4 reposts · 0 replies Open on X →
Unlock new standards in HCP analysis! Join our free webinar on ICH Q2(R2) qualification by LC-MS/MS, featuring USP & Alphalyse. Register now: https://t.co/qRdLse1gw2 #Biopharma #Proteomics #LCMS https://t.co/2Z7LVKHavU 1.2K views · 3 likes · 2 reposts · 0 replies Open on X →
Mark Your Calendar! Built Without Bacteria: Bringing Cell-Free Synthesis to the Bench Register for this free webinar sponsored by : https://t.co/sQw7FN0oje #Bacteria #Cloning #CRISPR #GenomeSequencing https://t.co/cixcASwJrT 1.1K views · 3 likes · 1 reposts · 0 replies Open on X →
Roundup: Removing Impurities from Biomanufacturing Boosting #biomanufacturing purity by reducing contaminants, improving quality, and increasing consistency @Agilent @LonzaGroup @MilliporeSigma @Repligen @SartoriusGlobal @Veranova_life @WuXiBiologics https://t.co/RZ5Ohjcx5b 1.2K views · 5 likes · 1 reposts · 0 replies Open on X →
@GENbio @julemieux1 @hoheyn @cnag_eu @OmniscopeAI I need to see the trial design. Everything else is speculation. 63 views · 0 likes · 0 reposts · 0 replies Open on X →
Human Cell Atlas at 10: A Decade of Discovery and the Road to HCA 2.0 @julemieux1 spoke with @hoheyn, @cnag_eu's ICREA professor and @OmniscopeAI co-founder about the meeting and the next 10 years. Heyn has been with the HCA since (almost) the beginning. https://t.co/IzbCz0e2rk 3.1K views · 7 likes · 4 reposts · 1 replies Open on X →

เทียบกับบัญชีขนาดเดียวกัน

12 โพสต์จาก 90 วันที่ผ่านมา เทียบกับช่วง 10K–100K ผู้ติดตาม ต่ำกว่าบัญชีรุ่นเดียวกันทั้งการเข้าถึงและการมีส่วนร่วม.

ยอดดูมัธยฐาน1 105บัญชีนี้924ค่ามัธยฐานของ 10K–100K
การเข้าถึง, %1.23%บัญชีนี้3.62%ค่ามัธยฐานของ 10K–100K
การมีส่วนร่วม, %0.82%บัญชีนี้1.52%ค่ามัธยฐานของ 10K–100K
ตัวชี้วัดบัญชีนี้ค่ามัธยฐานของ 10K–100Kอัตราส่วน
ยอดดูมัธยฐานต่อโพสต์1 1059241.20×
การเข้าถึง (ยอดดู ÷ ผู้ติดตาม)1.23%3.62%0.34×
อัตราการมีส่วนร่วม0.82%1.52%0.54×

บัญชีอื่นในช่วงนี้ →   เปรียบเทียบกับบัญชีอื่น →   ค่าอ้างอิงเหล่านี้คำนวณอย่างไร →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3.1K19 Aug
63
1.2K3 Sep
1.1K
1.2K4 Sep
1K
1.6K
1.1K16 Sep
1.6K
85017 Sep
548
464

Last 12 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.41%19 Aug
0.00%
0.51%3 Sep
0.37%
0.43%4 Sep
0.58%
1.74%
1.06%16 Sep
1.09%
2.00%17 Sep
1.28%
1.08%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes56.4%79 in total
Reposts22.9%32 in total
Replies3.6%5 in total
Quotes2.9%4 in total
Bookmarks14.3%20 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

บัญชีที่คล้ายกัน